BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4976218)

  • 1. [Experimental study on the evaluation of BCG-immunity in guinea pigs by airborne infection (supplemental study)].
    Toyohara M; Shimoide H
    Kekkaku; 1969 Jan; 44(1):7-11. PubMed ID: 4976218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study on evaluation of BCG-immunity in mice by airborne infection].
    Toyohara M; Shimoide H
    Kekkaku; 1969 Jul; 44(7):203-6. PubMed ID: 4899861
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
    Basaraba RJ; Izzo AA; Brandt L; Orme IM
    Vaccine; 2006 Jan; 24(3):280-6. PubMed ID: 16153758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs.
    Wiegeshaus EH; McMurray DN; Grover AA; Harding GE; Smith DW
    Am Rev Respir Dis; 1970 Sep; 102(3):422-9. PubMed ID: 5450906
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological changes after BCG vaccination and infection with virulent Mycobacterium tuberculosis].
    Chernushenko EF; Kogosova LS; Isaeva EG; Shaposhnik EN; Kuznetsova LV
    Probl Tuberk; 1978 Aug; (8):63-7. PubMed ID: 100780
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
    Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
    J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs.
    Smith DW; McMurray DN; Wiegeshaus EH; Grover AA; Harding GE
    Am Rev Respir Dis; 1970 Dec; 102(6):937-49. PubMed ID: 4991996
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of dispersed or surface grown cultures, manufacture and control methods on BCG standardization.
    Gheorghiu M; Lagrange PH; Lagranderie M; Balazuc AM
    Dev Biol Stand; 1986; 58 ( Pt A)():191-205. PubMed ID: 3297863
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of V.D.S. (diffusible killed antitubercular vaccine Salvioli) on the course of experimental tuberculosis in guinea-pigs evoked by H 37 Rv strain bacilli.
    Fafrowicz B; Szmygin J
    Clin Pediatr (Bologna); 1970 Jul; 52(7):299-302. PubMed ID: 4998498
    [No Abstract]   [Full Text] [Related]  

  • 12. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Mycobacterium bovis BCG-Praha on the growth of Daels' guinea-pig sarcoma (author's transl)].
    Schwartz E
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):497-509. PubMed ID: 4152732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proceedings: Immunology of Mycobacterium and its infection].
    Kekkaku; 1975 Mar; 50(3):49-57. PubMed ID: 805315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of latent bacillary state in patients with destructive pulmonary tuberculosis].
    Kaiupova MKh; Makarevich NM; Gedymin LE
    Probl Tuberk; 1972; 50(7):24-8. PubMed ID: 4626205
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of tubercle bacilli with various degrees of drug-resistance in the organs of guinea pigs.
    Lukjan Z; Rogowski F; Kunda M
    Arch Immunol Ther Exp (Warsz); 1973; 21(4):535-42. PubMed ID: 4201057
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of orotic acid and 4-amino-5-imidazolecarboxamide orotate on infection of mice with tubercle bacilli].
    Tsukamura M; Toyama H
    Kekkaku; 1969 Apr; 44(4):117-21. PubMed ID: 4978327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.